55 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... anticoagulants (DOACs ... ) for VTE treatment ... prevention - Comparison Table ... #DOAC #Anticoagulants
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Warfarin and DOAC ... Target - Prodrug - Bioavailability ... h) #Warfarin #DOAC ... #Pharmacology #NOAC ... #comparison #table
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison #Table
Best practice recommendations for the diagnosis and treatment of adult patients experiencing traumatic brain injury during
diagnosis and treatment ... injury during treatment ... with oral anticoagulants ... Brain #Injury #NOAC ... #DOAC #Management
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... direct-acting oral ... direct-acting oral ... #Cancer #Algorithm
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Management of DOACs ... direct acting oral ... interruption per treatment ... table ... Perioperative #Management #Treatment
Oral Anticoagulation Management Cheat Sheet: Warfarin, Apixaban, Dabigatran, Rivaroxaban
 - Mechanism of Action
 - Routine Blood
Oral Anticoagulation ... - Resume #Oral ... Anticoagulant #DOAC ... #Management #Table
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... algorithm for symptomatic ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... ) Cancer-treatment ... DOACs are substrates ... metabolization of DOACs ... #Interactions #Table
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... consider switching to oral ... if good bioavailability ... if good bioavailability ... #Bacteremia #Treatment